Tag: Biotech startup

  • Kiran Mazumdar Shaw: How Biocon Founder Became India’s First Biotech Queen?

    India is among the top 12 biotechnology destinations in the world, comprising around 600 biotech companies. In this article, you are going to find information about such a person who has made wealth all on his own, with sheer hard work and perseverance.

    Kiran Majumdar Shaw is an Indian Entrepreneur and Philanthropist who founded a biotechnology company, Biocon Limited in Bangalore, India. She is the Chairperson and Managing Director of Biocon. She received the Othmer Gold Medal for her exceptional contributions to the progress of science and chemistry. Financial Times named her in the business list of top 50 women. Forbes listed her as the 65th most powerful woman in the world. She was also named EY World Entrepreneur Of The Year 2020. She was ranked #2 in the Women Philanthropist list of 2019 by the Hurun Report India Philanthropy List 2019. As of the year 2020, she has an estimated net worth of $4.6 billion.

    Kiran Mazumdar is the executive chairperson and the founder of one of the most prominent biopharmaceutical companies around the globe, Biocon Limited. Kiran is a person who is an inspiration to thousands of women out there who are aspiring to become entrepreneurs. Read Kiran Mazumdar Shaw’s Success Story and know more about the journey of this amazing and inspiring woman.

    Kiran Mazumdar Shaw – Biography

    Name Kiran Mazumdar-Shaw
    Year of Birth 23 March 1953
    Nationality Indian
    Education Graduate degree in brewing from the University of Ballarat, Melbourne
    Profession Entrepreneur, Brewmaster
    Title Executive Chairperson – Biocon Limited and Biocon Biologics Limited
    Net Worth 370 crores USD
    Spouse John Shaw

    Kiran Mazumdar Shaw – Personal Life
    Kiran Mazumdar Shaw – Education
    Kiran Mazumdar Shaw – Professional Life & Career
    Kiran Mazumdar Shaw – Founder of Biocon
    Kiran Mazumdar Shaw – Expansion of Biocon
    Kiran Mazumdar Shaw – Board Memberships
    Kiran Mazumdar Shaw – Challenges Faced in Entrepreneurship
    Kiran Mazumdar Shaw – Success story
    Kiran Mazumdar Shaw – Philanthropy
    Kiran Mazumdar Shaw – Awards & Recognitions

    Kiran Mazumdar Shaw Success Story

    Kiran Mazumdar Shaw – Personal Life

    Kiran Mazumdar-Shaw and John Shaw
    Kiran Mazumdar-Shaw and John Shaw

    Kiran Mazumdar-Shaw was born to Gujarati parents in Banglore on 23rd March 1953, in a middle-class family. Her father, Rasendra Mazumdar was the head brewmaster at United Breweries.

    Since childhood, she aspired to become a doctor but couldn’t get a scholarship. In 1974, she was the only girl pursuing brewery course and topped in her class. At the age of 44, Kiran got married to John Shaw in the year 1989. John was working as the chairman at Madura Coats but left the job to join Biocon with Kiran. John Shaw is serving as the Vice Chairman of Biocon since 2001.

    Kiran Mazumdar Shaw – Education

    Kiran initially wanted to follow in her father’s footsteps. She studied at Bangalore’s Bishop Cotton Girl’s high school.

    She then took a pre-university course from an affiliate of Bangalore University, Mount Carmel College. She further graduated with a bachelor’s degree in zoology from Bangalore University in 1973.

    Kiran wanted to pursue medical college but was unable to get any scholarship in any medical college. Her father then suggested to pursue fermentation science and get trained as a brewmaster, which is a very non-traditional field for women. She went to Ballarat College, Melbourne University in Australia to study malting and brewing. She earned her degree of master brewer in 1975. Kiran Shaw was the only woman who opted for the brewing course and with her intelligence, she topped in her class.

    Kiran Mazumdar Shaw – Professional Life & Career

    Kiran Mazumdar-Shaw with Leslie Auchincloss
    Kiran Mazumdar-Shaw with Leslie Auchincloss

    Kiran started her professional career from Carlton and United Breweries, Melbourne, where she worked as a trainee brewer. Kiran Mazumdar completed her training in Carlton and United Breweries. She also worked at Barrett Brothers and Burston, Australia, as a trainee maltster.

    After coming back to India, she joined Jupiter Breweries in Calcutta as a technical consultant, and after gaining some experience there she worked as a Technical Manager at Standard Maltings Corporation situated in Baroda. She opted to further her career in Bangalore or Delhi but was told that “it’s a man’s profession” and that woman would not be employed as a master brewer in India.

    She started looking for work overseas and was given a position in Scotland. Leslie Auchincloss, the founder of Biocon Biochemicals Limited, of Cork, Ireland met Mazumdar before she could relocate. His firm produced enzymes used in the brewing, food packaging, and textile sectors.

    He was searching for an Indian entrepreneur to assist in the formation of a subsidiary in India. Kiran worked with the firm, and this was a life-changing opportunity for her. Leslie prepared her to work as a manager at his firm. Kiran went to India and began working for Biocon in a leased garage in Bangalore with an initial investment of 10,000 INR after she had a better understanding of the company’s operations and sales.

    Kiran Mazumdar Shaw – Founder of Biocon

    Kiran Mazumdar Shaw Founded Biocon Logo
    Kiran Mazumdar Shaw Founded Biocon Logo

    Kiran started with Biocon in 1978, she faced many challenges because of her youth, gender, and her untested business model. No bank wanted to lend her money, thus funding was a big issue.

    After getting her first funding she started with her first factory which was in a nearby 3000 sq. ft shed. The extraction of papain (a papaya enzyme used to tenderize the meat) and isinglass were the company’s first efforts (obtained from tropical catfish and used to clarify beer).

    Biocon India was the first Indian firm to make enzymes and ship them to the United States and Europe within a year of its founding. Kiran invested her first year’s profits in a 20-acre property, with plans to grow in the future. Kiran transformed Biocon India from an enzyme manufacturing firm to a fully integrated biopharmaceutical company because of her unique thinking and ideas.

    In 1984 Kiran discovered some new dimensions. At Biocon, a research and development team was created to focus on the development of innovative solid substrate fermentation methods. Biocon Pharmaceuticals was the first Indian biotech business to obtain funding from the United States for unique technology.

    Kiran started looking for alternative opportunities which were cost-effective as well low-cost. She had also proposed that drug companies be cost-sensitive in marketing to developing countries so that people can afford the drugs they need.

    Kiran and her husband John have always seen the need to provide people with the best they can, thus increasing and supplying affordable vaccines and medicines in India and helping society to overcome their medical requirements.

    Kiran Mazumdar Shaw – Expansion of Biocon

    Biocon Subsidiaries
    Biocon Subsidiaries

    She managed to establish two subsidiaries of Biocon including, Syngene in 1994 and Clinigene in 2000. Syngene provided a contractual basis early research and development support service while Clinigene focused on clinical research trials and the development of both generic and new medicines. Clinigene was later merged in Syngene and it has a current market cap of Rs.14,270.

    She incorporated Biocon Biopharmaceuticals Private Limited (BBLP) in 1990 to manufacture and market a select range of biotherapeutics in a joint venture with the Cuban Center of Molecular Immunology.


    Upasana Taku – Mobikwik Co- Founder | Biography | Education
    Upasana Taku, Mobikwik Co-Founder, is the first Indian woman leader in fintech. Read the biography of Upasana Taku and know her success mantra.


    Kiran Mazumdar Shaw – Board Memberships

    She is a member of the board of governors of the Indian School of Business and a term member of on the board of MIT, USA till 2023. She has been a former member of the Indian Institute of Technology Hyderabad. She was the first woman to head the board of governors of the Indian Institute of Management Bangalore (IIMB).

    She is an independent director on the board of Infosys. She is a member of the General Body of Maharashtra State Innovation Society. She is also a member of the advisory board of the MIT Jameel Clinic.

    Kiran Mazumdar Shaw – Challenges Faced in Entrepreneurship

    She started with a seed capital of Rs.10,000. Inspite of being a joint venture, Indian laws restricted foreign ownership to only 30% of the company. Thus, 70% of the company belonged to Kiran Mazumdar Shaw.

    She faced reliability challenges because of her youth, gender, and untested business model. She was unable to secure funding for her company initially. She tried hard and finally got her first financial backing. She also struggled while recruiting people to work for her startup. She had to face technological changes with an eye to building a biotech business in India, which was then having a poor infrastructure.


    Top 35 Successful Women Entrepreneurs In India [2022 Updated List]
    Women entrepreneurship is growing at a fast pace in Idnia. so we have listed some of the most successful women entrepreneurs in India.


    Kiran Mazumdar Shaw – Success story

    Kiran met Leslie Auchincloss, who is the founder of Biocon Biochemicals Limited, of Cork, Ireland. The aforesaid company produces enzymes to be used in brewing, food packaging, and textile industries. Auchincloss was desperately looking for an entrepreneur in India, who would help her in establishing an Indian subsidiary of Biocon.

    Kiran agreed to undertake the offer on a condition that if she did not wish to continue post six months, she would be given the position of brewmaster. She started working as a trainee manager at Biocon Limited, Cork, Ireland to learn more of the business. Post the training period, she returned India to establish the business.

    In 1989, Biocon Biochemicals of Ireland was acquired from Leslie Auchincloss by Hindustan Unilever. The partnership with Unilever helped Biocon to establish best practices and quality systems across the world. Unilever then sold its chemical division including Biocon to Imperial Chemical Industries (ICI). Her husband, John Shaw invested $2 million to purchase the shares of Biocon from ICI.

    Kiran Mazumdar Shaw – Philanthropy

    Kiran Mazumdar-Shaw The Giving Pledge
    Kiran Mazumdar-Shaw The Giving Pledge

    With the great success of her company, Biocon has allowed Kiran to donate and be the support of the people who need help but do not have the resources. Kiran is a firm believer in sharing and cares about people hence giving at least half of her wealth to philanthropic work. This was when she joined The Giving Pledge movement in the year 2015.  

    With the support of her husband John, she started up with Mazumdar Shaw Foundation in India to help the needful. The key sectors of the foundation are Education, Healthcare, Art & Culture, and a Healthy Environment. The Foundation is involved in numerous health and education outreach programs to benefit the economically weaker sections of Indian society.

    Mazumdar Shaw Medical Center
    Mazumdar Shaw Medical Center

    Mazumdar Shaw foundation has also established a 1400 bed cancer care center in Bangalore, in collaboration with Devi Shetty. Her goal is to create a world-class cancer center with affordable treatment.

    Kiran Mazumdar Shaw – Awards & Recognitions

    Kiran Mazumdar honoured by the Government of India
    Kiran Mazumdar honoured by the Government of India

    Kiran Mazumdar has been awarded several times for her leadership and  success in entrepreneurship.

    • She has been Conferred with the Bombay Management Association (BMA) Business Leader of The Decade Award in 2022.
    • She has been awarded with the “Spirit of TiE – Trailblazers Award” by TiE Bangalore on World Entrepreneurs Day in 2021.
    • Biocon has been recognized among the Top 20 in the The Medicine Maker Power List 2019 under the Business Captains category in 2019.
    • Kiran has received Padma Shri in the year 1989 and Padma Bhushan in the year 2005.
    • Recipient of EY World Entrepreneur of the Year (2020) and EY Entrepreneur of the Year India Award (2019).
    • Recipient of Order of Australia (2020).
    • Recipient of ICMR’s Lifetime Achievement Award for Outstanding Achievement in Healthcare (2019).
    • Recipient of AWSM Award for Excellence (2017).
    • Knight of the National Order of the French Legion of Honour (2016).
    • Recipient of Othmer Gold Medal (2014).
    • Recipient of Global Economy Prize for Business (2014).
    • Ranked among the world’s 16 Most Powerful Women in Leadership in 2021 by CEO Magazine.

    Kiran is also fond of writing books and she loves reading novels. She has written and has got published two books: ‘Ale and Arty’ and ‘India’s Innovation Challenge for Inclusive Development.

    Conclusion

    The second richest self-made woman in India is the star and pride of the nation. Nobody knew about Kiran Mazumdar-Shaw but now she is one of the most influential women in the country. She has shown the world that a woman can do everything and is a living inspiration for young woman entrepreneurs.

    FAQs

    Who is the husband of Kiran Mazumdar-Shaw?

    Kiran Mazumdar-Shaw is married to John Shaw.

    How old is Kiran Mazumdar-Shaw?

    Kiran Mazumdar-Shaw was born on 23 March 1953 and is 69 years old (2022).

    What is the net worth of Kiran Mazumdar-Shaw?

    Kiran Mazumdar-Shaw has a net worth of  $370 crores as of 2022.

    What is Kiran Mazumdar-Shaw’s education?

    Kiran Mazumdar-Shaw has done bachelor’s degree in zoology from Bangalore University in 1973 and earned a degree as master brewer in 1975 from Melbourne University in Australia.

  • Serum Institute of India – Leading Biotechnology Firm

    Company Profile is an initiative by StartupTalky to publish verified information on different startups and organizations. The content in this post has been approved by Serum Institute of India.

    India has reported more than 19 million cases since the pandemic started, second only to the United States. There have also been over 200,000 deaths recorded. A total of 150 million vaccine shots have been administered, covering 11.5 percent of India’s 1.3 billion population. Serum Institute of India is India’s leading biotechnology firm, producing highly advanced life-saving biologicals such as vaccines, antisera, and other medical specialties using cutting-edge genetic and cell-based technologies. Dr. Cyrus Poonawalla established the Serum Institute of India in 1966 with the aim of producing life-saving immuno-biologicals

    Serum Institute of India Pvt. Ltd. is now the world’s largest vaccine manufacturer, with more than 1.5 billion doses manufactured and distributed worldwide.

    Know the complete Success story of Serum Institute and get a glance on on how Serum Institute started, its revenue, business model, its role in Covid-19 vaccine development, competitors & more…

    Serum Institute – Company Highlights

    Startup Name Serum Institute of India
    Headquarters Hadapsar, Pune, India
    Industry Biotechnology, Pharmaceuticals
    Founder Cyrus S. Poonawalla
    Founded 1966
    Current CEO Adar Poonawalla
    Subsidiaries Vakzine Projekt Management GmbH, Bilthoven Biologicals BV
    Areas Served Worldwide
    Website www.seruminstitute.com

    Serum Institute – Recent News
    About Serum Institute and How It Works?
    Serum Institute – Name, Logo and Tagline
    Serum Institute – Founder and History
    Serum Institute – Mission and Vision
    Serum Institute – Covid 19 Vaccine Development
    Serum Institute – Revenue and Growth
    Serum Institute – Investments
    Serum Institute – Acquisitions
    Serum Institute – Competitors
    Serum Institute – Challenges Faced
    Serum Institute – Future Plans
    Serum Institute – FAQs

    Serum Institute of India – Recent News

    May 2021 – CEO Adar Poonawalla, who has been in the United Kingdom on an extended stay to avoid alleged threats in India over rising demand for COVID-19 vaccines, has announced that he will return in a few days.


    About Serum Institute of India and How It Works?

    Serum Institute of India Pvt. Ltd. is now the world’s largest vaccine manufacturer, with more than 1.5 billion doses manufactured and distributed worldwide, including Polio vaccine, Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps, and Rubella vaccines.

    Serum Institute vaccines are administered to approximately 65 percent of the world’s children. The Serum Institute’s vaccines are approved by the World Health Organization in Geneva and are used in over 170 countries around the world as part of their national immunization programmes, saving millions of lives.

    The Serum Institute of India uses cutting-edge technology to scan its goods for minute particles that are undetectable by the naked eye. The inspection is completely automated, with high resolution CCD cameras and an electronic monitored panel, reducing the margins of human error.

    Tetanus antitoxin, snake antivenom, DPT vaccine, and MMR vaccine were among the first drugs manufactured in large quantities by the Serum Institute of India. Vaccines against bacterial and viral infections, combined vaccines, influenza vaccine, and meningococcal vaccine were added to the company’s product line.


    How Startups can scale up Covid vaccination drive in India
    Covid has created a large negative impact on most of the industries in thesector. It has disrupted the economic activities in the country. Most of thesectors are being impacted due to the pandemic. Let’s look at how the variousstartups can help the government in the Covid-19 vaccination drive. H…


    Serum Institute of India – Mission and Vision

    Serum Institute’s mission is to develop high-quality vaccines and make them affordable to a wide range of countries, allowing them to increase their Health Index. The Serum Institute was founded to ensure that vaccines are no longer a privilege for Indian children.

    Serum Institute began supplying high-quality, but affordable vaccines to many countries around the world after achieving this aim. International agencies such as the WHO, PATH, NIH, NVI/RIVM, and CBER/USFDA have collaborated with Serum Institute to produce vaccines against Meningococcal A, H1N1 Influenza, Rotavirus, and other diseases.

    Serum Institute of India – Name, Logo and Tagline

    Serum Institute of India’s tagline says, “Serum – Protection from birth onwards”. The company is the world’s largest vaccine manufacturer and produces vaccines(including Polio vaccine, Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps, and Rubella vaccines) that protect people from birth onwards.

    Serum Institute Logo

    Serum Institute of India – Founder and History

    Dr. Cyrus Poonawalla established the Serum Institute of India in 1966 with the aim of producing life-saving immuno-biologicals that were in short supply in India and had to be imported at a high cost.

    Founder of SII - Dr. Cyrus Poonawalla
    Founder of SII – Dr. Cyrus Poonawalla

    Following that, many life-saving biologicals were produced at reasonable prices and in large quantities, resulting in the country being self-sufficient in Tetanus Anti-toxin and Anti-snake Venom serum, then DTP (Diphtheria, Tetanus, and Pertussis) vaccines, and finally MMR (Measles, Mumps, and Rubella) vaccines.

    Vaccines against bacterial and viral infections, combined vaccines, influenza vaccine, and meningococcal vaccine were added to the company’s product line. Apart from vaccines, the company also produces antisera, blood plasma, and hormones. The Serum Institute of India’s vaccines has been used in international vaccination programs run by the World Health Organization (WHO), UNICEF, and the Pan American Health Organization as of 2014. (PAHO). The Poonawalla Group now runs the Serum Institute of India, which is involved in research, production, and manufacturing.

    In 2009, the company started working on a swine flu vaccine that would be administered intranasally. Bilthoven Biologicals, a pharmaceutical firm in the Netherlands, was the company’s first foreign purchase in 2012.

    The Serum Institute of India developed Rabies Human Monoclonal Antibody (RMAb), also known as Rabishield, with help from Mass Biologics of the University of Massachusetts Medical School in the United States.

    CEO of SII - Adar Poonawalla
    CEO of SII – Adar Poonawalla

    By 2020, the company will have developed 1.5 billion vaccine doses each year, making it the world’s largest vaccine manufacturer by amount of doses produced. Tuberculosis vaccine Tubervac (BCG), poliomyelitis vaccine Poliovac, and other childhood vaccines are among the products created.


    List of Biotech companies that are Developing Covid vaccine
    India started its vaccination programme for Covid-19 on 16 January 2021. Thevaccination was first prioritized for frontline and healthcare workers. TheCovishield vaccine and Covaxin have been approved by the government. There aremany more companies working behind developing the vaccine in the cou…


    Serum Institute of India – Covid 19 Vaccine Development

    AstraZeneca, a British-Swedish multinational pharmaceutical firm, has teamed up with Oxford University to grow AZD1222. According to reports, Serum Institute will provide India and other low- and middle-income countries with 100 million (10 crores) vaccine doses.

    By the end of 2021, the target had been raised to one billion doses. It’s expected to cost about $3 per dose or around 225 dollars. Trials were suspended by DCGI in September 2020 after a volunteer in Oxford became ill after being vaccinated, but were quickly resumed after British regulators agreed. The Serum Institute of India applied for emergency approval for the vaccine produced with AstraZeneca in December 2020, and it was granted a month later. A deal was reached in March 2021 to supply certain doses to the United Kingdom.

    The Serum Institute of India has also agreed to produce Novavax’s NVX-CoV2373 vaccine for India and other low- and middle-income countries. Codagenix’s nasal COVID-19 vaccine CDX-005 will also be manufactured by the company (tradename COVI-VAC)


    19 Innovative Health Startups in India | List of Top Healthcare Startups
    The hunger for success makes you forget about health. You might be engrossedwith your startup but don’t work yourself to death for a bright entrepreneurialfuture. A wise man once said that health is wealth[https://startuptalky.com/tag/wealth-management/]. The healthcare sector is growing rapidl…


    Serum Institute of India – Revenue and Growth

    SII’s net sales in 2018-19 were Rs 5,238 crore, with an after-tax profit of Rs 2,252 crore. The compounded annual growth rate (CAGR) for revenue was 8.1 percent over five years (2014-2019), while the CAGR for profit after tax was 5.3 percent. In 2019, SII’s export earnings accounted for more than two-thirds of its net sales. At the end of 2019, it had total assets of Rs 16,703 crore.

    The pharma giant AstraZeneca and the University of Oxford collaborated on the Covid-19 vaccine. Covishield has a 62 percent efficacy rate. The SII has already generated a stock of approximately 5 crore doses. By February, it claims to be able to increase production to 10 crore doses per month.

    Serum Institute of India – Investments

    Date Organization Name Round Amount
    Jul 23, 2019 X-Vax Technology Series A $56M
    Oct 5, 2017 Visterra Series C $23.6M

    Serum Institute of India – Acquisitions

    Acquiree Name About Acquire Date Amount
    Nanotherapeutics Privately held specialty biopharmaceutical company with product development, cGMP manufacturing capabilities Apr 25, 2017 €72M


    Indian Startups Acquisition – Updated List
    This is an effort to put up all the latest acquisition in the Indian StartupEcosystem at one place. Indian Startups Acquisition data listDate Aquirer Aquiree About Acquirer About Acquiree Value March 12, 2021 Samunnati Kamatan Samunnati is an Agri value chain solutions provider thatenables grow…


    Serum Institute of India – Competitors

    Biocon, Panacea Biotec, Bharat Serums, Wockhardt, Biological E, Bharat Biotech, Syngene International, Indian Immunologicals, Premas Biotech, Reliance Life Sciences, and Zydus Cadila are among the other leading competitors in Serum Institute’s competitive set.

    Cadila Healthcare, India’s fifth largest pharmaceutical firm, is working on an indigenous vaccine for the novel coronavirus in addition to producing Covid treatment drugs like remdesivir. Phase-III trials on 26,000 Indian patients have been approved by the government. The vaccine’s price has yet to be determined by Cadila.


    List of Top 15 Pharmaceutical Companies in India 2021 | StartupTalky
    Due to the COVID-19 pandemic [https://startuptalky.com/tag/covid-19/], Healthcare[https://startuptalky.com/healthcare-business-ideas-india/] facilities and medicines havebecome the need of the hour. India, the second-largest populated country, havealso seen numerous cases of Covid-19 and the numb…


    Serum Institute of India – Challenges Faced

    According to Poonawalla, the real challenge in 2020 will be determining if the Covid vaccine will actually function and be effective in humans. It was also difficult to demonstrate its effectiveness and plan a trial in a country where outbreaks are likely to occur, most likely China.

    According to the CEO, “Our journey now is looking and has lot of challenges because we are trying to enter the Europe and US markets. We are trying to sensitize the Indian government to take more vaccines and plan and help them in their programmes to fight these life threatening diseases. We have got other challenges from China and other countries where we are offering a red carpet treatment for them to come here, but when we want to go to China, we have got a lot of barriers that we are facing like parting with our technology, we have got to do joint ventures things which are impossible.”

    Serum Institute of India – Future Plans

    As it struggles to fulfil supply obligations, the Serum Institute of India, which manufactures the AstraZeneca Covid-19 vaccine, is considering starting vaccine manufacturing in other countries.

    “There’s going to be an announcement in the next few days,” Adar was quoted.

    Poonawalla said the Serum Institute would be able to increase its monthly production to 100 million doses by July, a month later than the previous goal of end-May. Vaccines against Covid-19 have run out in some Indian states.

    Within six months, he planned to increase the Serum Institute’s capability from 2.5 billion to 3 billion doses per year. He flew to London until Britain imposed an eight-day travel ban on Indians.

    Serum Institute of India – FAQs

    What does SII do?

    Serum Institute of India is India’s leading biotechnology firm, producing highly advanced life-saving biologicals such as vaccines, antisera, and other medical specialties using cutting-edge genetic and cell-based technologies.

    Who founded SII?

    Dr. Cyrus Poonawalla established the Serum Institute of India in 1966 with the aim of producing life-saving immuno-biologicals that were in short supply in India and had to be imported at a high cost.

    Does SII produce Covid Vaccine?

    Yes, SII produces Covid vaccine.

    Does SII export Covid vaccine?

    Yes, SII exports Covid vaccine out of India.

  • Cyrus Poonawalla: Vaccine King of India

    Cyrus Poonawalla is an Indian businessman and Philanthropist who is the Chairman of Cyrus Poonawalla Group, which includes the Indian biotech company, Serum Institute of India. He is also known as “vaccine king of India”, because his firm manufactures pediatric vaccines and contributes towards society by providing low-cost vaccines to the masses. As a Philanthropist, he supplied 100 thousand doses of measles vaccines for free vaccination in Ukraine in partnership with an Ukrainian businessman, Naum Koen. As of January 2021, he has an estimated net worth of $11.50 billion.

    Cyrus Poonawalla- Biography

    Name Cyrus S. Poonawalla
    Born 1941
    Hometown Pune, India
    Age 80 (2021)
    Nationality Indian
    Education Brihan Maharashtra College of Commerce
    Profession Businessman, Philanthropist
    Position Chairman of Poonawalla Group; Founder of Serum Institute of India
    Net worth $11.50 billion (Jan 2021)
    Spouse Villoo Poonawalla
    Children Adar Poonawalla
    Awards Padma Shri (2005)

    Cyrus Poonawalla – Personal Life
    Cyrus Poonawalla – Education
    Cyrus Poonawalla – Professional Life
    Cyrus Poonawalla – Business idea
    Cyrus Poonawalla – Cyrus Poonawalla Group
    Cyrus Poonawalla – Serum Institute of India
    Cyrus Poonawalla – Poonawalla Stud Farms & Horse Racing
    Cyrus Poonawalla – Honors & Awards


    Top 50 Richest Indians in 2020: Comprehensive List
    India is home to some insanely wealthy families and individuals known across theglobe. India has the third largest group of rich people[/demerits-disadvantage-rich/] after the US and China — 121 people out of the2068 individuals that Forbes took into account for its annual ranking wereIndians. W…


    Cyrus Poonawalla – Personal Life

    Cyrus was born in a Parsi family and his father was a horse-breeder. The family had a business of horse racing and they owned the Poonawalla Stud Farms. He is married to Villoo Poonawalla, who died in 2010 due to cardiac arrest. The couple has a son named, Adar Poonawalla, who currently serves as the Chief Executive Officer of Serum Institute of India.

    Cyrus Poonawalla – Education

    Cyrus completed his elementary education from Bishops School, Pune. He completed his graduation Brihan Maharashtra College of Commerce (BMCC) in 1966. He acquired a PhD in 1988 by Pune University for the thesis named “Improved Technology in the Manufacture of Specific Anti-toxins and its Socio-Economic Impact on the Society.”

    Cyrus Poonawalla – Professional Life

    At age 20, Cyrus realized that his family business of horse racing had no future ahead. He then started experimenting with cars and built a $120 prototype sports car modeled on the D-type Jaguar along with a friend, however, they did not have enough capital to produce such cars on commercial basis.

    He thus dropped the idea and thought of manufacturing cars for masses rather targeting the elite community of society. At that time, horses were donated to Haffkine Institute in Mumbai, a government owned firm that manufactured vaccines using horse serum.

    Cyrus Poonawalla – Business idea

    Cyrus noted the scope in the serum industry and decided to take upon the challenge of producing vaccines by extracting horse serum. He aimed at availing these vaccines and supplying it across the country at affordable prices.

    He raised $12,000 along with his brother Zavaray by selling horses and requested their father to contribute the required capital. In 1966, they eventually established their venture on a 12 acre plot and started manufacturing vaccines.

    Cyrus Poonawalla – Cyrus Poonawalla Group

    Cyrus founded the Cyrus Poonawalla Group and serves as its Chairman. The biotech firm, Serum Institute of India is also founded by him and it is a portal of the Group. The Cyrus Poonawalla Group of companies deal with pharmaceuticals & biotechnology, finance, clean energy, hospitality & reality, and aviation. The company is headquartered in Pune, India.  

    The group runs several companies across diverse sectors like, Poonawalla Finance, Bilthoven Biologicals, Poonawalla Aviation, Villoo Poonawalla Greenfield Farms, Poonawalla Clean Energy, Poonawalla Hospitality and Real Estate. The company also runs philanthropic firms like, Villoo Poonawalla Foundation, Adar Poonawalla Clean City Initiative, and Tennis Academy.

    Cyrus Poonawalla – Serum Institute of India

    Cyrus founded Serum Institute of India (SII) in 1966 with an aim to manufacture life-saving immuno-biologicals in India. The company is recognized as India’s No. 1 biotechnology firm with the world’s largest vaccine manufactured, produced and sold globally.

    The company launched its first therapeutic anti-tetanus serum within two years of the establishment. Gradually, they started manufacturing DTP vaccine, Measles vaccine. SII is presently India’s leading Biotech company and is currently exporting vaccines to more than 140 countries across the world.

    His son, Adar started serving as the CEO of SII from 2011 and he expanded the business with new licensed and pre-qualified products by the World Health Organization (WHO) to supply it to the United Nations Agencies.


    Top Biotech Startups In India: Leading To A Healthy Future
    In India, the biotechnology sector is one of the fastest-growing industries. Thecompanies under top biotech startups in India is known for providing betterdiagnosis, high-quality drugs, and making the medicines and MedTec productsavailable at a reasonable price. They aim at getting the best outco…


    Cyrus Poonawalla – Poonawalla Stud Farms & Horse Racing

    The Poonawalla Stud Farms was owned by his late-father and he used to ran house racing and breeding industry. The farm is currently handled by Cyrus and his brother. It is one of the leading stud farm in the country.

    He solely represented India at the International Federation of Horse Racing authorities and was a member of the Asian Racing Federation (ARF) for more than 10 years. He held various positions in the horse racing field like, Chairman, Turf Authorities of India, Vice Chairman of Asian Racing Federation, and Royal Western India Turf Club etc.


    Kiran Majumdar Shaw | Founder & Chairperson of Biocon Limited | Women Philanthropist |
    Kiran Majumdar Shaw is an Indian Entrepreneur and Philanthropist who founded abiotechnology company, Biocon Limited in Bangalore[https://www.startuptalky.com/bangalore-startups/], India. She is the Chairperson and Managing Director of Biocon. She received the Othmer Gold Medal for her exceptiona…


    Cyrus Poonawalla – Honors & Awards

    • He received the fourth-highest civilian award, Padma Shri by the President of India in 2005.
    • On 20 November 2007, he received the Ernst & Young “Entrepreneur of the Year 2007” under the category of Healthcare and Life Sciences.
    • On 5 February 2015, he received the Ernst & Young “Entrepreneur of the Year 2014”.
    • On 3 June 2018, he was conferred with the Honorary degree of Doctor of Humane Letters by The University of Massachusetts Medical School.
    • On 26 June 2019, he was conferred with the Honorary Doctorate of Science by the University of Oxford.

    Frequently Asked Questions – FAQs

    Who is the CEO of Serum Institute of India?

    Adar Poonawalla, currently serves as the Chief Executive Officer of Serum Institute of India.

    What is Cyrus Poonawalla net worth?

    As of January 2021, Cyrus Poonawalla has an estimated net worth of $11.50 billion.

    Who is Naum Koen?

    Naum Koen is an UAE-based Israeli-Ukrainian businessman and philanthropist who is the founder and CEO of NY Koen Group.